A carregar...

Ertugliflozin in the treatment of type 2 diabetes mellitus

More than 422 million people worldwide have diabetes, with 90–95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outcomes with sodium–glucose cotransporter 2 (SGLT2) inhi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Context
Main Authors: Marrs, Joel C, Anderson, Sarah L
Formato: Artigo
Idioma:Inglês
Publicado em: BioExcel Publishing Ltd 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7707814/
https://ncbi.nlm.nih.gov/pubmed/33293984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!